Company: CL
Filing Date: 2025-01-24
Form Type: 8-K/A
Source: 0000021665-25-000002
Chunk: 1

Company: COLGATE PALMOLIVE CO
Filing Date: 2025-01-24
Form: 8-K/A
Chunk 1
---
 Stock Exchange                  |
| 1.375% Notes due 2034         |     | CL34              |     | New York Stock Exchange                  |
| 0.875% Notes due 2039         |     | CL39              |     | New York Stock Exchange                  |

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

#### Explanatory Note
This Amendment No. 1 on Form 8-K/A is being filed by Colgate-Palmolive Company (the “Company”) solely to ensure an additional item number tag (Item 2.02) is reflected in the EDGAR system for the Company’s Current Report on Form 8-K filed with the Securities and Exchange Commission (“SEC”) on October 25, 2024 (the “Report”). No other changes are being made to the Report or to the exhibits attached thereto, including Exhibits 99.1 and 99.2

Item 2.02. Results of Operations and Financial Condition.

On October 25, 2024, Colgate-Palmolive Company (the “Company”) issued a press release announcing its earnings for the quarter ended September 30, 2024. This press release is attached as Exhibit 99.1 and is incorporated herein by reference.

The information in Item 2.02 of this Current Report is being furnished and shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section. The information in Item 2.02 of this Current Report shall not be incorporated by reference into any registration statement or other document pursuant to the Securities Act of 1933, as amended.

#### Item 8.01. Other Events.
In connection with management changes, the Company realigned the reporting structure of its skin health business effective July 1, 2024. Accordingly, commencing with the Company’s financial reporting for the quarter ended